l-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys

[1]  A. Parent,et al.  Dopaminergic neurons intrinsic to the striatum , 2007, Journal of neurochemistry.

[2]  A. Parent,et al.  The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. , 2006, Brain : a journal of neurology.

[3]  T. Di Paolo,et al.  Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors , 2006, Synapse.

[4]  E. Hirsch,et al.  New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. , 2006, Brain : a journal of neurology.

[5]  Y. Smith,et al.  Synaptic microcircuitry of tyrosine hydroxylase‐containing neurons and terminals in the striatum of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated monkeys , 2006, The Journal of comparative neurology.

[6]  A. Parent,et al.  Chemical characterization of newly generated neurons in the striatum of adult primates , 2006, Experimental Brain Research.

[7]  G. Torres,et al.  The dopamine transporter proteome , 2006, Journal of neurochemistry.

[8]  T. Di Paolo,et al.  Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  P. Hof,et al.  Prenatal protracted irradiation at very low dose rate induces severe neuronal loss in rat hippocampus and cerebellum , 2005, Neuroscience.

[10]  A. Parent,et al.  Neurochemical characterization of dopaminergic neurons in human striatum. , 2005, Parkinsonism & related disorders.

[11]  J. Thibault,et al.  Degeneration of dopaminergic neurons triggers an expression of individual enzymes of dopamine synthesis in non-dopaminergic neurons of the arcuate nucleus in adult rats , 2005, Journal of Chemical Neuroanatomy.

[12]  A. Parent,et al.  Morphology and distribution of dopaminergic neurons intrinsic to the human striatum , 2005, Journal of Chemical Neuroanatomy.

[13]  A. Parent,et al.  Tyrosine hydroxylase‐positive neurons intrinsic to the human striatum express the transcription factor Nurr1 , 2004, The European journal of neuroscience.

[14]  J. Benoit,et al.  Striatal tyrosine hydroxylase immunoreactive neurons are induced by l-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats , 2004, Neuroscience Letters.

[15]  H. Okano,et al.  Cortical and Striatal Expression of Tyrosine Hydroxylase mRNA in Neonatal and Adult Mice , 2003, Cellular and Molecular Neurobiology.

[16]  Yubao Jiang,et al.  Factors Influencing the Differentiation of Dopaminergic Traits in Transplanted Neural Stem Cells , 2003, Cellular and Molecular Neurobiology.

[17]  A. Parent,et al.  Dopaminergic Neurons in Human Striatum and Neurogenesis in Adult Monkey Striatum , 2003 .

[18]  J. Labandeira-Garcia,et al.  Localization and functional significance of striatal neurons immunoreactive to aromatic l-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models , 2003, Brain Research.

[19]  E. Snyder,et al.  Neural Stem Cells Spontaneously Express Dopaminergic Traits after Transplantation into the Intact or 6-Hydroxydopamine-Lesioned Rat , 2002, Experimental Neurology.

[20]  A. Parent,et al.  Proliferating cells can differentiate into neurons in the striatum of normal adult monkey , 2002, Neuroscience Letters.

[21]  R. Bakay,et al.  Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration , 2002, The Journal of Neuroscience.

[22]  O. Hornykiewicz,et al.  Increase of Preproenkephalin mRNA Levels in the Putamen of Parkinson Disease Patients with Levodopa‐Induced Dyskinesias , 2002, Journal of neuropathology and experimental neurology.

[23]  T. Nakahara,et al.  Neuronal ectopic expression of tyrosine hydroxylase in the mouse striatum by combined administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 3-nitropropionic acid , 2001, Neuroscience.

[24]  L. Mao,et al.  Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration. , 2001, Brain research. Developmental brain research.

[25]  N D Stull,et al.  Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. , 2001, Brain research. Developmental brain research.

[26]  A. Parent,et al.  The Nigrostriatal Pathway in the Rat: A Single-Axon Study of the Relationship between Dorsal and Ventral Tier Nigral Neurons and the Striosome/Matrix Striatal Compartments , 2001, The Journal of Neuroscience.

[27]  L. Iacovitti,et al.  Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line , 2001, Brain Research.

[28]  G. Donnan,et al.  New dopaminergic neurons in Parkinson's disease striatum , 2000, The Lancet.

[29]  L. Grégoire,et al.  Sustained Cabergoline Treatment Reverses Levodopa-Induced Dyskinesias in Parkinsonian Monkeys , 2000, Clinical neuropharmacology.

[30]  A. Parent,et al.  Chemical heterogeneity of the striosomal compartment in the human striatum , 1999, The Journal of comparative neurology.

[31]  T. Di Paolo,et al.  Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys , 1999, Synapse.

[32]  Martin Lévesque,et al.  Extrastriatal dopaminergic innervation of human basal ganglia , 1999, Neuroscience Research.

[33]  M. Smidt,et al.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  X. Du,et al.  Multiple signaling pathways direct the initiation of tyrosine hydroxylase gene expression in cultured brain neurons. , 1997, Brain research. Molecular brain research.

[35]  R. Turner,et al.  Dopaminergic Neurons Intrinsic to the Primate Striatum , 1997, The Journal of Neuroscience.

[36]  B J Hoffer,et al.  Dopamine neuron agenesis in Nurr1-deficient mice. , 1997, Science.

[37]  X. Du,et al.  Protein Kinase C Activators Work in Synergy with Specific Growth Factors to Initiate Tyrosine Hydroxylase Expression in Striatal Neurons in Culture , 1997, Journal of neurochemistry.

[38]  S. Young,et al.  Aromaticl-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenousl-DOPA to dopamine , 1995, Brain Research.

[39]  X. Du,et al.  Synergy between growth factors and transmitters required for catecholamine differentiation in brain neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  André Parent,et al.  Chemical anatomy of primate basal ganglia , 1995, Progress in Neurobiology.

[41]  L. Iacovitti,et al.  Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons , 1995, Brain Research.

[42]  A. Parent,et al.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.

[43]  L. Iacovitti.  Effects of a novel differentiation factor on the development of catecholamine traits in noncatecholamine neurons from various regions of the rat brain: studies in tissue culture , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  S. Haber,et al.  Mechanisms of striatal pattern formation: conservation of mammalian compartmentalization. , 1990, Brain research. Developmental brain research.

[45]  A. Graybiel.  Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.

[46]  A. Parent,et al.  Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry , 1989, The Journal of comparative neurology.

[47]  T. Hattori,et al.  Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat , 1989, Neuroscience Letters.

[48]  Richard F. Martin,et al.  Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidence , 1987, Neuroscience Letters.

[49]  C. D. Stern,et al.  Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.

[50]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[51]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[52]  C. Marsden.  The mysterious motor function of the basal ganglia , 1982, Neurology.

[53]  C. Ockleford,et al.  Propidium iodide as a nuclear marker in immunofluorescence. I. Use with tissue and cytoskeleton studies. , 1981, Journal of immunological methods.

[54]  E. Spokes,et al.  Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. , 1980, Brain : a journal of neurology.

[55]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[56]  O. Hornykiewicz,et al.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy. , 1975, The Journal of pharmacology and experimental therapeutics.

[57]  M. Waring,et al.  Complex formation between ethidium bromide and nucleic acids. , 1965, Journal of molecular biology.

[58]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[59]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.